Sell 4/12/2024Downgrade
Disc Medicine, Inc. (IRON) was downgraded to D- from D on 4/12/2024 due to a noticeable decline in the volatility index, growth index and solvency index. Operating cash flow declined 138.04% from -$7.48M to -$17.8M, earnings per share declined from -$0.5808 to -$0.9645, and EBIT declined 56.74% from -$18.96M to -$29.71M.

Sell 8/14/2023Downgrade
Disc Medicine Opco Inc (IRON) was downgraded to D from D+ on 8/14/2023 due to a major decline in the efficiency index and volatility index.

Sell 6/13/2023Upgraded
Disc Medicine Opco Inc (IRON) was upgraded to D+ from E+ on 6/13/2023 due to an increase in the total return index.

Sell 6/2/2023Upgraded
Disc Medicine Opco Inc (IRON) was upgraded to E+ from E on 6/2/2023 due to a significant increase in the solvency index, efficiency index and total return index. The quick ratio increased from 8.62 to 23.69, and total capital increased 31.57% from $177.93M to $234.11M.

Sell 3/28/2023None
Disc Medicine, Inc. (IRON) was downgraded to E from U on 03/28/2023.